The FDA has issued Emergency Use Authorization for several diagnostic tests for Zika to assist in the public health response. In this CAPcast, Dr. Benjamin Pinsky, Stanford University Medical Center’s Director of the Clinical Virology Laboratory, discusses the types of testing available as well as the new Vector Bourne Disease Survey from the CAP, which is designed to provide an extra measure of quality assurance for laboratories performing molecular Zika testing.